Insights

U.S. CBP announced that Phase I of CAPE, the new tariff refund technology within ACE, will be available for use on April 20, 2026. Learn the details.

Explore 4 biopharma industry trends highlighted at the 2606 MassBio State of Possible Conference and key considerations for biopharmaceutical leaders.

Explore why SOC report quality matters more than speed and how credible assurance hinges on rigor, operating effectiveness and evidence‑based testing.

Explore why AI in hiring doesn't replace a solid talent strategy and learn the core elements organizations need to use it effectively in the hiring process.

Explore the essential steps of the IPO timeline. Learn how long it takes to go public and key IPO timing insights for a successful market debut.

CBP filed a declaration with the U.S. CIT on ACE system progress regarding CAPE. Learn what importers should expect for IEEPA tariff refunds.

Understand how the new excise tax on remittance transfers, introduced under the One Big Beautiful Bill Act, works and its implications for RTPs.

Uncover why organizations gain an advantage by recruiting talent based on proven capabilities and outcomes, not titles, in today's productivity-first market.

Get key facts about the new USTR Section 301 investigations relating to excess manufacturing capacity and failure to enforce the ban on forced labor.

Learn governance, risk management and regulatory considerations for financial institutions evaluating cannabis-related business banking programs.